Holen Sie sich die Stockscreener-App
2.35
7.31%
0.16
Handel nachbörslich:
2.40
0.05
+2.13%
Schlusskurs vom Vortag:
$2.19
Offen:
$2.23
24-Stunden-Volumen:
1.88M
Relative Volume:
1.74
Marktkapitalisierung:
$27.21M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-23.36M
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+40.72%
1M Leistung:
+92.62%
6M Leistung:
+3.30%
1J Leistung:
-87.37%
1-Tages-Spanne:
$2.20
$2.47
1-Wochen-Bereich:
$1.60
$3.89
52-Wochen-Spanne:
$0.73
$26.30
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
Firmenname
Calidi Biotherapeutics Inc
Sektor
Branche
Telefon
(858) 794-9600
Adresse
4475 Executive Drive, Suite 200, San Diego
Vergleichen Sie CLDI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| CLDI | 2.35 | 27.21M | 0 | -23.36M | 0 | 0.00 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Calidi Biotherapeutics Inc Aktie (CLDI) Neueste Nachrichten
Calidi Biotherapeutics Reveals Promising Virotherapy Data - TipRanks
Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer - EIN News
Calidi presents data on RTNova systemic technology in metastatic lung cancer - TipRanks
Calidi Bio's RTNova Shows Promise in Metastatic Lung Cancer Treatment Breakthrough | CLDI Stock News - StockTitan
Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock - The Manila Times
Calidi Biotherapeutics Raises $7.5M Through Public Offering of 4.4M Shares | CLDI Stock News - StockTitan
Pre-market Movers: GANX, TFFP, AKYA, CLDI... - RTTNews
SEC Form 424B5 filed by Calidi Biotherapeutics Inc. - Quantisnow
Calidi prices 4.4M shares at $1.69 in public offering - TipRanks
Calidi Biotherapeutics announces pricing of $7.5M public offering of common stock - MSN
Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock - The Manila Times
Calidi Biotherapeutics Raises $7.5M in Public Offering for Clinical Trials | CLDI Stock News - StockTitan
Calidi announces common stock offering, no amount given - TipRanks
Calidi Biotherapeutics Surges on 3Q Report, Retreats on Stock-Offer News - MarketWatch
Calidi Biotherapeutics plans stock offering - Investing.com India
Calidi Biotherapeutics Announces Proposed Public Offering - The Manila Times
Calidi Biotherapeutics Launches Public Stock Offering to Fund Corporate Growth | CLDI Stock News - StockTitan
Calidi Biotherapeutics Advances with FDA Clearance and Funding - TipRanks
Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results - The Manila Times
Calidi Bio Gets FDA Nod for Brain Cancer Drug Trial Amid $5.1M Q3 Loss | CLDI Stock | CLDI Stock News - StockTitan
Calidi Biotherapeutics’ $2.1 Million Shares Offering - Global Legal Chronicle
Contrasting BioCryst Pharmaceuticals (NASDAQ:BCRX) & Calidi Biotherapeutics (NYSE:CLDI) - Defense World
CLDICalidi Biotherapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Calidi Biotherapeutics’ (NYSE American: CLDI) Groundbreaking Cancer Treatment on RedChip’s Bloomberg TV Program - Barchart
Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
Calidi to present data supporting RTNova at upcoming conferences - TipRanks
Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences - The Manila Times
Calidi to sell 2.05M shares at $1.00 in registered direct offering - Yahoo Finance
Calidi Biotherapeutics stock tumbles on $2M securities offering - MSN
CLDI stock touches 52-week low at $0.95 amid sharp annual decline By Investing.com - Investing.com South Africa
CLDI stock touches 52-week low at $0.95 amid sharp annual decline - Investing.com
Why Calidi Biotherapeutics (CLDI) Stock Is Down 13% - Benzinga
Calidi Biotherapeutics secures $2 million in equity financing - Investing.com
Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement - The Manila Times
Calidi Biotherapeutics Faces Warrant Delisting by NYSE - Yahoo Finance
NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS) - The Manila Times
Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
Exchange Income Corp (EIF-T) QuotePress Release - The Globe and Mail
Cocoa #7 (CAU21) Quote - The Globe and Mail
Wendy Pizarro - Los Angeles Times
CLDI stock touches 52-week low at $1 amid market challenges - Investing.com Canada
Adv Micro Devices (AMD-Q) QuotePress Release - The Globe and Mail
Calidi Biotherapeutics Gains FDA Nod for Brain Cancer Trial - TipRanks
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 - U.S. Politics Today
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma - The Manila Times
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application - The Bakersfield Californian
Calidi Biotherapeutics announces board changes and auditor ratification - Investing.com
Calidi Biotherapeutics Presents Antitumor Virotherapy Advances - TipRanks
Calidi Biotherapeutics stock target cut by Baird with Outperform tag maintained - Investing.com
Calidi price target lowered to $2.50 from $20 at Baird - TipRanks
CLDI Stock Earnings: Calidi Biotherapeutics Beats EPS for Q2 2024 - MSN
Finanzdaten der Calidi Biotherapeutics Inc-Aktie (CLDI)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
Kapitalisierung:
|
Volumen (24h):